Cargando…
SEPT9 Gene Methylation as a Noninvasive Marker for Hepatocellular Carcinoma
BACKGROUND: Early detection appears to be the most effective approach to improve the overall survival of patients with hepatocellular carcinoma (HCC). We evaluated the potential performance of plasma SEPT9 methylation (mSEPT9) as a noninvasive biomarker for the diagnosis of patients with HCC. METHOD...
Autores principales: | Li, Baoliang, Huang, Hao, Huang, Ronghai, Zhang, Wei, Zhou, Guangpeng, Wu, Zhen, Lv, Chunhua, Han, Xiaoliang, Jiang, Li, Li, Yongjun, Li, Baohua, Zhang, Zhongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647768/ https://www.ncbi.nlm.nih.gov/pubmed/33178361 http://dx.doi.org/10.1155/2020/6289063 |
Ejemplares similares
-
Plasma-Methylated SEPT9 for the Noninvasive Diagnosis of Gastric Cancer
por: Zhao, Luyao, et al.
Publicado: (2022) -
Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer
por: Fu, Bo, et al.
Publicado: (2018) -
Role of Plasma methylated SEPT9 for Predicting Microvascular Invasion and Tumor Proliferation in Hepatocellular Carcinoma
por: Huang, Fei, et al.
Publicado: (2022) -
SNHG3 Affects Gastric Cancer Development by Regulating SEPT9 Methylation
por: Li, Wei, et al.
Publicado: (2022) -
Methylated SEPT9 combined with AFP and PIVKA-II is effective for the detection of HCC in high-risk population
por: Zheng, Kepu, et al.
Publicado: (2023)